My name is Mark Herndon, Chief Financial Officer of Horizon Kinetics. We're pleased to have you join us for our call that will cover our results for the fourth quarter and full year of 2025. But first ...
President Trump's plan to ban big investors from home ownership may not be the key to reviving the American Dream in ...
8don MSN
Fake product recall notices are the latest scam targeting consumers: ‘Something seemed fishy’
Consumer Reports is warning of a new kind of scam — phony recall notices. Recall notices warn consumers of potential safety ...
DEScycle’s commercialization strategy is built around small-scale, repeatable infrastructure deployed close to feedstock.
BACKGROUND: With the increasing diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) at earlier stages and new therapies, there is a rising demand for tools to stratify risk and prognosis. We ...
Peer-reviewed economic analysis finds a combined ESR + CRP testing strategy reduces misdiagnoses and delivers net cost ...
Need a quote from a Motley Fool analyst? Stephen Altemus, and Chief Financial Officer, Peter McGrath, are leading the call ...
As ADC pipelines expand rapidly, innovations in payload linker chemistry are becoming a key enabler of next-generation ...
Is ESR Worth Keeping? Combining ESR with CRP reduces misdiagnoses and generates substantial net cost savings compared to ordering CRP alone. A new ALCOR Scientific sponsored peer-reviewed study ...
Collaboration leverages Converge Bio's proprietary generative AI to design and optimize novel tri-specific antibodies for oncology needsAI-driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results